Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Epstein-Barr virus (EBV) plays a critical role in various diseases, necessitating accurate methods to study its gene expression.
• Understanding the differential expression of latent and lytic EBV transcripts is crucial for diagnosing and managing EBV-related conditions.

Purpose of the Study:

• To develop and validate two multiplex-nested reverse transcription-polymerase chain reaction (RT-PCR) assays for simultaneous detection of EBV latent/immortalizing and lytic transcripts.
• To assess the utility of these assays in evaluating EBV gene expression profiles in immunocompetent and immunosuppressed patient cohorts.

Main Methods:

• Development of two distinct multiplex-nested RT-PCR assays targeting specific EBV latent (EBNA1, EBNA2, LMP1, LMP2) and lytic (Zebra, VCA) transcripts.
• Validation of the assays using peripheral blood mononuclear cells (PBMC) from immunocompetent individuals (primary EBV infection, past infection, no infection) and immunosuppressed patients (renal and liver transplant recipients, including those with PTLD).

Main Results:

• The developed multiplex-nested RT-PCR assays demonstrated reliability, rapidity, and sensitivity in detecting EBV transcripts.
• Simultaneous identification of seven key latent/immortalizing and lytic EBV transcripts was achieved.
• The assays successfully evaluated EBV latent/lytic gene expression in diverse patient groups, including transplant recipients with and without PTLD.

Conclusions:

• The novel multiplex-nested RT-PCR assays provide a robust system for the simultaneous detection and identification of multiple EBV transcripts.
• These assays are valuable tools for investigating the EBV transcriptional profile in EBV-related diseases across both immunocompetent and immunocompromised populations.
• The developed methodology facilitates further research into the pathogenesis and clinical management of EBV-associated disorders.